Skip to main content
. 2004 Mar;111(3):273–281. doi: 10.1111/j.0019-2805.2004.01816.x

Table 1.

Checkerboard analysis of hBD-2-induced neutrophil migration

(a)
hBD-2 in upper chamber (mg/ml)

hBD-2 in lower chamber (mg/ml) 0 1 2·5 5 10
0 41 ± 6 32 ± 5 39 ± 9 51 ± 4 26 ± 7
1 76 ± 4 44 ± 2 26 ± 4 39 ± 8 61 ± 9
2·5 169 ± 33 107 ± 27 76 ± 11 38 ± 6 53 ± 4
5 286 ± 62 223 ± 39 157 ± 17 114 ± 23 59 ± 5
10 158 ± 17 99 ± 16 73 ± 11 82 ± 8 79 ± 7
(b)
MIP-3α in upper chamber (μg/ml)
hBD-2 in lower chamber (μg/ml) 0 1 2 4 8
0 41 ± 6 52 ± 2 37 ± 7 53 ± 5 36 ± 7
1 76 ± 4 73 ± 9 46 ± 6 37 ± 9 44 ± 5
2·5 169 ± 33 152 ± 26 109 ± 21 68 ± 12 69 ± 5
5 286 ± 62 263 ± 43 188 ± 37 103 ± 8 67 ± 5
10 158 ± 17 134 ± 17 99 ± 25 70 ± 6 82 ± 3

Various concentrations of hBD-2 were added to the lower chambers, and TNF-α-treated neutrophils in the upper chambers containing either hBD-2 (a) or MIP-3α (b) at indicated concentrations were allowed to migrate. The migratory response was measured after a 60 min-incubation by counting the number of cells through the polycarbonate membrane. Each value represents the mean ± SD of three separate experiments.